| Literature DB >> 33805494 |
Abstract
The forward head posture (FHP) of stroke patients has a negative impact on respiratory function. Cervical spine mobilization is a manual therapy technique that used to prevent and treat FHP and respiratory function. This pilot study investigated whether cervical spine mobilization can effectively improve outcomes following FHP and respiratory function of stroke patients. Twenty-four patients participated in our assessor-blinded randomized controlled trial. All the participants received neurodevelopmental treatments (gait training and trunk rehabilitation). The experimental group additionally received 15-min sessions of cervical spine mobilization three times per week for 4 weeks. The control group received cervical spine sham mobilization during the same period. For the cervical angles, the cranial vertebral angle (CVA) and cranial rotation angle (CRA) were measured. A respiratory function test was performed to measure the forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), peak expiratory flow (PEF), maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), and chest circumferences (upper and lower chest sizes). Except for MIP, there was no significant difference between the experimental group and the control group. The CVA and CRA were significantly increased in the experimental group only. Cervical spine mobilization improved cervical angles and inspiratory function of the stroke patients in this study. However, a comparative study with a larger number of patients is needed to confirm this finding from our pilot study, which had a small sample size.Entities:
Keywords: CVA; FHP; MIP; cervical spine; joint mobilization; stroke
Year: 2021 PMID: 33805494 PMCID: PMC8066151 DOI: 10.3390/healthcare9040377
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Subject characteristics.
| Classification | Experimental Group ( | Control Group ( | ||
|---|---|---|---|---|
| Gender (male/female) | 8/4 | 8/4 | 0.100 | |
| Paretic side (left/right) | 7/5 | 9/3 | 0.667 | |
| Pathogenesis (hemorrhages/infarction) | 9/3 | 7/5 | 0.667 | |
| Disease duration (months) a | 13.92 ± 3.32 | 14.42 ± 3.03 | 0.662 | |
| Age (years) a | 66.33 ± 10.58 | 65.50 ± 9.18 | 0.795 | |
| Weight (kg) a | 64.00 ± 8.34 | 65.30 ± 8.49 | 0.686 | |
| Height (cm) a | 165.34 ± 8.56 | 165.57 ± 8.08 | 0.729 | |
| K-MMSE (point) a | 26.25 ± 2.01 | 26.33 ± 2.06 | 0.953 |
a Values are denoted as mean ± SD; b Chi-square test; c Mann–Whitney U test; K-MMSE: Korean-mini mental state examination; Experimental group: cervical joint mobilization; control group: sham joint mobilization.
Changes of cervical angle on two intervention groups.
| Measure/Group | Baseline Test a | Post Test a | Mean Difference a | Within Group Difference b | Between Group Difference c | |
|---|---|---|---|---|---|---|
| CVA (°) | Experimental group | 43.27 ± 2.49 | 47.15 ± 4.08 | 3.88 ± 3.69 | Z = −2.746 | U = 41.000 |
| Control group | 42.19 ± 2.90 | 43.88 ± 5.15 | 1.69 ± 3.11 | Z = −1.570 | ||
| CRA (°) | Experimental group | 147.62 ± 9.47 | 152.10 ± 5.74 | 1.41 ± 11.45 | Z = −2.197 | U = 62.000 |
| Control group | 145.65 ± 7.85 | 148.63 ± 9.70 | 0.85 ± 8.54 | Z = −1.648 | ||
a Values are means ± SD. b Values of Wilcoxon signed rank test. c Values of Mann Whitney U test. * Within group difference: significant increase than the baseline test. Experimental group: cervical joint mobilization. Control group: sham joint mobilization. CVA: cranial vertebral angle. CRA: cranial rotation angle.
Changes of respiratory function on two intervention groups.
| Measure/Group | Baseline Test a | Post Test a | Mean Difference a | Within Group Difference b | Between Group Difference c | |
|---|---|---|---|---|---|---|
| FVC | Experimental group | 2.77 ± 0.57 | 3.13 ± 0.46 | 0.37 ± 0.29 | Z = −2.758 | U = 44.000 |
| Control group | 2.68 ± 0.53 | 2.87 ± 0.56 | 0.19 ± 0.21 | Z = −2.601 | ||
| FEV1 | Experimental group | 2.34 ± 0.62 | 2.59 ± 0.54 | 0.26 ± 0.19 | Z = −2.847 | U = 49.000 |
| Control group | 2.30 ± 0.50 | 2.46 ± 0.49 | 0.16 ± 0.15 | Z = −2.848 | ||
| PEF | Experimental group | 260.58 ± 71.24 | 314.42 ± 61.62 | 53.83 ± 40.59 | Z = −2.847 | U = 43.000 |
| Control group | 254.08 ± 69.56 | 283.25 ± 75.52 | 29.17 ± 28.72 | Z = −2758 | ||
| MIP (mmHg) | Experimental group | 39.67 ± 5.91 | 52.33 ± 3.73 | 12.67 ± 5.23 | Z = −3.065 | U = 22.000 |
| Control group | 39.50 ± 5.28 | 45.33 ± 3.80 | 5.83 ± 4.22 | Z = −3.070 | ||
| MEP (mmHg) | Experimental group | 53.08 ± 11.08 | 70.17 ± 11.13 | 17.08 ± 9.98 | Z = −3.061 | U = 44.000 |
| Control group | 52.50 ± 10.47 | 63.58 ± 9.63 | 11.08 ± 5.12 | Z = −3.061 | ||
| Upper chest circumference (cm) | Experimental group | 1.61 ± 0.57 | 2.49 ± 0.84 | 0.88 ± 0.99 | Z = −2.551 | U = 70.000 |
| Control group | 1.42 ± 0.53 | 2.19 ± 0.71 | 0.78 ± 0.87 | Z = −2.356 | ||
| Lower chest circumference (cm) | Experimental group | 1.78 ± 0.61 | 2.76 ± 0.77 | 0.98 ± 1.06 | Z = −2.601 | U = 67.500 |
| Control group | 1.68 ± 0.44 | 2.53 ± 0.68 | 0.85 ± 0.73 | Z = −2.551 | ||
a Values are means ± SD. b Values of Wilcoxon signed rank test. c Values of Mann Whitney U test. * Within group difference: significant increase than the baseline test. ** Between group difference: significant increase than the control group. Experimental group: cervical joint mobilization. Control group: sham joint mobilization. FEV1: forced expiratory volume at the 1 s. FVC: forced vital capacity. PEF: peak expiratory flow. MIP: maximal inspiratory pressure. MEP: maximal expiratory pressure.